![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61P 35/00 | (2018.01) | ||
C07D 519/00 | (2006.01) | ||
C07D 471/04 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 519/00 | (2013.01) | ||
A61K 31/437 | (2006.01) | ||
A61K 45/06 | (2013.01) |
(11) | Number of the document | 4143187 |
(13) | Kind of document | T |
(96) | European patent application number | 21723390.7 |
Date of filing the European patent application | 2021-04-27 | |
(97) | Date of publication of the European application | 2023-03-08 |
(45) | Date of publication and mention of the grant of the patent | 2024-05-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2021/053486 |
Date | 2021-04-27 |
(87) | Number | WO 2021/220170 |
Date | 2021-11-04 |
(30) | Number | Date | Country code |
PCT/CN2020/087831 | 2020-04-29 | WO |
(72) |
FAIRHURST, Robin Alec , CH
FRITSCH, Christine , CH
GERSPACHER, Marc , CH
HINRICHS, Jürgen Hans-Hermann , CH
LANGLOIS, Jean-Baptiste Georges Armand , CH
LEBLANC, Catherine , CH
LI, Tengfei , CN
LORTHIOIS, Edwige Liliane Jeanne , CH
MURA, Christophe , CH
NIETO-OBERHUBER, Cristina Montserrat , CH
TODOROV, Milen , CH
VAUPEL, Andrea , CH
WARIN, Nicolas , CH
WILCKEN, Rainer , CH
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2-ALPHA AND THEIR METHODS OF USE |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2-ALPHA AND THEIR METHODS OF USE |